Preclinical characterization and clinical development of ILARIS® (canakinumab) for the treatment of autoinflammatory diseases
Author:
Funder
Novartis Pharma AG, Basel
Publisher
Elsevier BV
Subject
Biochemistry,Analytical Chemistry
Reference53 articles.
1. Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics;Lainka;Klin Pädiatrie,2010
2. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes;Simon;Am J Physiol Regul Integr Comp Physiol,2007
3. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome;Hoffman;Nat Genet,2001
4. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases;Aksentijevich;Arthritis Rheum,2002
5. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis;Aganna;Arthritis Rheum,2002
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A grey zone in canakinumab tapering: dose reduction or interval prolongation?;Rheumatology;2024-01-30
2. Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial;Journal of Clinical Oncology;2024-01-10
3. Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer;Cancers;2023-11-21
4. Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review;Terapevticheskii arkhiv;2022-10-12
5. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies;Experimental Cell Research;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3